spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Genomics Research 2014

Genomics Research 2014 (SelectBio)

29-30 April 2014
South San Francisco Conference Center, San Francisco, CA, USA

SELECTBIO’s Genomics Research 2014 conference will feature an integrated program of tracks designed to cover the latest developments in single cell PCR, qPCR in diagnostics, next-generation sequencing platforms and methods, microRNA-based gene expression and epigenetics in development.  The two track conference coverage of these topics will include speakers from academic institutions, as well as commercial organisations, in a manner that brings together the basic science with the applications in these growing segments.

The tracks and topics at this meeting will be:

dPCR & Next-Gen Sequencing – Topics:

  • 3rd Generation Sequencing Technologies
  • Applications of Sequencing Data
  • Bioinformatics
    • Genex
    • LinReg PCR
    • qBase
  • New Research Developments and Applications
    • microRNA Applications
    • Expression Profiling
    • Fish Probes
    • HRM
    • PLA
    • Single Cell PCR
  • qPCR in Diagnostics
    • Antiterrorist Uses
    • Circulating Tumor Cells
    • Pathogen Detection
  • RNA-Seq
  • Sequencing Platforms and Methods
  • Toxicogenomics

Gene Silencing & Epigenetics – Topics:

  • Epigenetics as a Means to Modulate and Control Development
  • Epigenetics in Cancer
  • microRNA-based Gene Expression Modulation
  • RNAi in vivo

Keynote Speakers:

George Calin, Associate Professor, University of Texas MD Anderson Cancer Center

Hakim Djaballah, Director, High throughput Drug Screening Core Facility, Memorial Sloan Kettering Cancer Center

Eric Miska, Principal Investigator, University of Cambridge

John Burnett, Assistant Research Professor, Beckman Research Institute, City of Hope

Stephen Bustin, Professor of Allied Health and Medicine, Anglia Ruskin University

Register online, and remember you can register 2for1!    Early Bird/2for1 expires on 18 March 2014

You can present your research on a poster while attending the meeting.

Also featured will be an exhibition of vendors displaying the most-recent technologies and products in these fields.

phone +44 178 731 5124
email h.tweed@selectbio.com
web selectbiosciences.com/conferences/index.aspx?conf=GR2014
 
Print this page
Send to a friend
   
spacer
Industry Events

Emballage – Manutention 2014

17-20 November 2014, Paris Nord Villepinte Exhibition Centre, Paris – France

From 17th to 20th November 2014, EMBALLAGE and MANUTENTION will come together with a comprehensive and complementary offer for worldwide professionals from 4 business sectors: PACKAGING – PROCESSING – PRINTING – HANDLING.
More info >>

Banner of Scope.events on Samedan

White Papers

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>


News and Press Releases

CPhI 2014 Expert Industry Annual Report: Part i

Expert panel warns ‘IPR is stifling innovation’; predicts that a ‘process-centric approach will achieve global revenue savings of 20 to 25%’, with ‘green chemistry set to help drive manufacturing cost reductions’
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement